发明名称 ANTAGONISTIC HUMAN LIGHT-SPECIFIC HUMAN MONOCLONAL ANTIBODIES
摘要 <p>Disclosed is an isolated antibody, or functional fragment thereof, that specifically binds to a hLIGHT epitope wherein the antibody comprises: (a) i) a VH CDR 1 having the amino acid sequence of SEQ ID NO. 20; and ii) a VH CDR 2 having the amino acid sequence of SEQ ID NO. 21; and iii) a VH CDR 3 having the amino acid sequence of SEQ ID NO. 22; and (b) i) a VL CDR 1 having the amino acid sequence of SEQ ID NO. 35; and ii) a VL CDR 2 having the amino acid sequence of SEQ ID NO. 36; and iii) a VL CDR 3 having the amino acid sequence of SEQ ID NO. 37. Also disclosed is the use of the antibody for the manufacture of a composition for alleviating one or more symptoms of inflammatory bowel disease (IBD) in a human selected from abdominal cramps and pain, bloody diarrhea, severe urgency to have a bowel movement, fever, loss of appetite, weight loss, anemia, fatigue, and/or sores on lower legs, ankles, calves, thighs, and arms, profuse bleeding from intestinal ulcers, perforation or rupture of the bowel, strictures and obstruction, fistulae (abnormal passage) and perianal disease, toxic megacolon, and or malignancy of the colon or small intestine, arthritis, skin conditions, inflammation of the eye, liver and kidney disorders, and/or bone loss.</p>
申请公布号 NZ575163(A) 申请公布日期 2011.12.22
申请号 NZ20070575163 申请日期 2007.08.24
申请人 LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY;KYOWA HAKKO KIRIN CO., LIMITED 发明人 GRANGER, STEVEN, W
分类号 A61K39/395;A61P37/06;C07K16/28;C12N15/13;G01N33/53 主分类号 A61K39/395
代理机构 代理人
主权项
地址